FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2013/03/003518 [Registered on: 26/03/2013] Trial Registered Retrospectively
Last Modified On: 14/02/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to study outcomes of perioperative versus extended antimicrobial usage in tympanomastoid surgery for long standing middle ear diseases.  
Scientific Title of Study   Comparing outcomes in perioperative only versus extended antimicrobial usage in tympanomastoid surgery for chronic otitis media: A randomized controlled trial  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
U1111-1130-5168  UTN 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vijay G Bidkar 
Designation  Assistant Professor 
Affiliation  SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL 
Address  211 Shreyas Block SDM STAFF Quatrs Sattur Dharwad Karnataka
Department of ENT SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL DHARWAD KARNATAKA
Dharwad
KARNATAKA
580009
India 
Phone  919620886857  
Fax    
Email  vijay20dr@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vijay G Bidkar 
Designation  Assistant Professor 
Affiliation  SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL 
Address  211 Shreyas Block SDM STAFF Quatrs Sattur Dharwad Karnataka
Department of ENT SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL DHARWAD KARNATAKA
Dharwad
KARNATAKA
580009
India 
Phone  919620886857  
Fax    
Email  vijay20dr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vijay G Bidkar 
Designation  Assistant Professor 
Affiliation  SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL 
Address  211 Shreyas Block SDM STAFF Quatrs Sattur Dharwad Karnataka
Department of ENT SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL DHARWAD KARNATAKA
Dharwad
KARNATAKA
580009
India 
Phone  919620886857  
Fax    
Email  vijay20dr@gmail.com  
 
Source of Monetary or Material Support  
SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL 
 
Primary Sponsor  
Name  DEPARTMENT OF ENT 
Address  SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL DHARWAD 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Dr Ashok Naik  SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL DHARWAD KARNATAKA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR VIJAY BIDKAR  DEPARTMENT OF ENT  SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL
Dharwad
KARNATAKA 
9620886857

vijay20dr@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ACTIVE AND INACTIVE MUCOSAL DISEASE CHRONIC OTITIS MEDIA,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Only perioperative antimicrobial prophylaxis for 24 hrs  Intravenous Cefuroxime axetil 1.5 Gram preoperative loading dose given 30 minutes before incision as surgical antimicrobial prophylaxis followed by 750 mg of Cefuroxime axetil 12th hourly till 24 hours of postoperative period. 
Comparator Agent  Perioperative antimicrobial prophylaxis for 24 hrs and extended antimicrobial for 8 days  Intravenous Cefuroxime axetil 1.5 Gram preoperative loading dose given 30 minutes before incision as surgical antimicrobial prophylaxis followed by 750 mg of Cefuroxime axetil 12th hourly till 24 hours of postoperative period. Active control group perioperative antimicrobial prophylaxis after 24 hours is followed by oral Cefixime 200mg 12th hourly for 8 days  
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Active and inactive mucosal chronic otitis media
 
 
ExclusionCriteria 
Details  Squamosal chronic otitis media,Revision tympanomastoid surgery,Ossicular discontinuity requiring reconstruction, tympanosclerosis, Diabetes mellitus other systemic disorder.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Wound infection;Discharge from ear canal; Graft failure; adverse reaction to drug; Length of Hospital stay; revision due to failure
 
All the primary outcomes assessed individually at 1st, 2nd and 3rd week postoperatively
 
 
Secondary Outcome  
Outcome  TimePoints 
Otoendoscopic examination  1 month 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "83"
Final Enrollment numbers achieved (India)="83" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/01/2012 
Date of Study Completion (India) 30/05/2014 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 30/05/2014 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Bidkar VG, Jalisatigi RR, Naik AS, Shanbag RD, Siddappa R, Sharma PV, Hegde HV. Perioperative only versus extended antimicrobial usage in tympanomastoid surgery: a randomized trial. Laryngoscope. 2014 Jun;124(6):1459-63. doi: 10.1002/lary.24544. Epub 2014 Jan 15. PMID: 24307502. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is randomized, double blind, parallel group, active controlled trial comparing outcomes in perioperative only versus extended antimicrobial usage in tympanomastoid surgery for active and inactive mucosal chronic otitis media that will  be conducted at tertiary referal center ; Department of ENT, SDM College of Medical Sciences and Hospital, Dharwad, Karantaka, India.
The primary outcome measure will assess various parameters of infection leading surgical site infection and graft failure (re perforation) requiring revision surgery. Hence judicious and responsible antimicrobial policy can be practiced for these type of surgeries by otolaryngologists
 
Close